— Ticker · NMS —
TECH · Bio-Techne Corporation
Healthcare · Biotechnology
TECH
$52.01
▲ +8.16%
7-day move
7-day move
day$51.66 → $53.1852-wk$43.20 → $72.16avg vol2.6M / 3Mcap$8.1B
Plate I.
The Past Year, in One Line
The Valuation
| P/E (forward) | 25.2 |
| P/E (trailing) | 74.3 |
| EPS (forward) | $2.06 |
| EPS (trailing) | $0.70 |
| PEG | 0.70 |
| Dividend | 60.00% |
The Risk
| Beta | 1.36 |
| Short % float | 10.60% |
| Float | 156.0M |
| Shares out | 156.6M |
| Avg vol (3M) | 2.6M |
| 52w range | $43.20 → $72.16 |
The Analyst Tape
strong buybuyholdunderperformsell
$61.42
avg 12-mo target
+18.1%
vs. last · 12 analysts
The Pipeline
$8.1B
market cap
exchangeNMS
sectorHealthcare
industryBiotechnology
market cap$8.1B
websitebio-techne.com
The Briefs
live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for TECH in the last 7 days.
Word on the Street
StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for TECH.
Indicators That Mention TECH
5 of our 639 catalog map to TECH
SP-2500
Major US IPO day
1 on first-day-trading dates for major tech/consumer IPOs since 2000
(Google, FB, Twitter, Snap, Uber, Airbnb, Coinbase, Reddit, etc.).
↓54%
↓57%
↓63%
↓67%
↓70%
↓75%
●Still works on fresh data
r=0.01
SP-4764
Case-Shiller Seattle Home Price Index (monthly)
Seattle metro home prices tech-sector wage proxy.
↑55%
↑55%
↓53%
52%
49%
↓53%
●Still works on fresh data
r=0.15
SP-2484
LIT Lithium & Battery Tech ETF
Lithium miners + EV battery supply chain (Albemarle, SQM, battery tech).
49%
49%
51%
51%
50%
50%
●Still works on fresh data
r=-0.07
SP-4339
Kastle Office Occupancy Austin (weekly)
Austin office occupancy tech-heavy market.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-4585
Kastle Office Occupancy San Jose (weekly)
San Jose office occupancy pure tech/Silicon-Valley exposure.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 639 indicators against four horizons. By chance alone, ~128 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust.Other Players in the Pipeline
Biotech · by market cap · 7-day move
— Voices on TECH —commentarylive
Curated commentary (Kobeissi, Doomberg, Lyn Alden, QuoteTheRaven, Pomp, ZeroHedge) mentioning TECH. Opinion, not wire.
No recent commentary mentioning TECH in the last 7 days.
Analyst · previewYou're seeing the public read on TECH. Analyst unlocks every pundit call on TECH with open P&L + alerts when a new position opens + the full related-indicator firing history. Trader adds intraday quotes + cross-asset co-fire scoring with TECH as the target + the API / MCP feed.Compare tiers →